Wells Fargo Upgrades Regeneron Pharma (REGN) to Overweight
Tweet Send to a Friend
Wells Fargo analyst Jim Birchenough upgraded Regeneron Pharma (NASDAQ: REGN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
